GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silver Spike Investment Corp (NAS:SSIC) » Definitions » Net Cash per Share

Silver Spike Investment (Silver Spike Investment) Net Cash per Share : $4.76 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Silver Spike Investment Net Cash per Share?

Net Cash per Share is calculated as Balance Sheet Cash And Cash Equivalents plus Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Silver Spike Investment's Net Cash per Share for the quarter that ended in Dec. 2023 was $4.76.

The historical rank and industry rank for Silver Spike Investment's Net Cash per Share or its related term are showing as below:

SSIC' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.98   Med: 1.38   Max: 2.39
Current: 2.39

During the past 3 years, the highest Price-to-Net-Cash Ratio of Silver Spike Investment was 2.39. The lowest was 0.98. And the median was 1.38.

SSIC's Price-to-Net-Cash is ranked better than
89.23% of 260 companies
in the Drug Manufacturers industry
Industry Median: 7.78 vs SSIC: 2.39

Silver Spike Investment Net Cash per Share Historical Data

The historical data trend for Silver Spike Investment's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silver Spike Investment Net Cash per Share Chart

Silver Spike Investment Annual Data
Trend Mar21 Mar22 Dec23
Net Cash per Share
-0.04 13.56 4.76

Silver Spike Investment Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only - 5.05 5.09 4.51 4.76

Competitive Comparison of Silver Spike Investment's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Silver Spike Investment's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silver Spike Investment's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silver Spike Investment's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Silver Spike Investment's Price-to-Net-Cash falls into.



Silver Spike Investment Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Silver Spike Investment's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Silver Spike Investment's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Silver Spike Investment  (NAS:SSIC) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Silver Spike Investment Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Silver Spike Investment's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Silver Spike Investment (Silver Spike Investment) Business Description

Traded in Other Exchanges
N/A
Address
600 Madison Avenue, Suite 1800, New York, NY, USA, 10022
Silver Spike Investment Corp is a closed-end management investment company formed to invest in companies across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately-held cannabis businesses.
Executives
Umesh Mahajan officer: Chief Financial Officer 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Scott Gordon director, 10 percent owner, officer: Chief Executive Officer 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Gregory M. Gentile 10 percent owner, officer: CFO, CCO & Sec. 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Silver Spike Capital, Llc 10 percent owner 600 MADISON AVE, SUITE 1800, NEW YORK NY 10022
Warson Tracey Brophy director 1350 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Silver Spike Holdings, Lp 10 percent owner 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Michael William Chorske director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Vivek Bunty Bohra director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Silver Spike Holdings Gp, Llc 10 percent owner 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Da Corte Americo director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065